WELCOME TO THE MANUFACTURING REPORT
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
| April 20, 2016
Bayer, a Life Sciences company dedicated to health care and agriculture, significantly climbed up the list of America's most reputable companies in the 2016 U.S. RepTrak® 100 announced recently by Reputation Institute. According to the new list, which measures the public's perception of companies across a broad range of categories, Bayer ranked No. 38 among the Top 100 Most Reputable Companies in 2016. This marks a significant increase from Bayer's No. 68 ranking in 2015. The RepTrak® rankings m...
ELEMENTUM 3D | January 13, 2020
Additive manufacturing research and development company Elementum 3D has received investment from Sumitomo Corporation of Americas through its Series A funding round. The undisclosed amount has been given to Elementum in order to support its endeavours in the development of advanced metal, composites and ceramic materials for 3D printing. It represents SCOA’s fourth investment in the additive manufacturing market, after backing aerospace supplier Sintavia, manufacturer AREVO, and service b...
Manufacturing Global | January 13, 2020
Shannon Murphy, Assistant Head of Risk Underwriting and manufacturing specialist at Euler Hermes, examines the last 12 months and explains where the risks lie for the sector in the year ahead. Manufacturers around the world have had a challenging year in 2019. The impact of the ongoing trade dispute between the US and China and uncertainty surrounding the UK’s withdrawal from the EU have both contributed to the slowing of the global economy, which will have given the sector’s leaders...
Outsourcing-Pharma.com | January 13, 2020
BMS and Catalent disclosed the deal for the site in June, at which time they hoped to work through the regulatory approvals and union consultations needed to close the transaction by the end of the year. One week into 2020, Bristol-Myers revealed it had closed the deal. The deal covers a 19,300-square-meter manufacturing facility in Anagni, a town in central Italy, that lists cardiovascular, neuroleptics, anticancer, metabolic and anti-inflammatory medicines among the drugs it makes and packages...
MANUFACTURING TECHNOLOGY,FUTURE OF MANUFACTURING
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE